Publication | Closed Access

Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin®) eye drops against corneal neovascularization

Ocular DiseaseOphthalmologyTopical BevacizumabTopical DrugWound HealingGlaucomaEye DropsOcular PharmacologyMedicineCorneal Neovascularization